Oncosil Medical ROE 2024

Oncosil Medical Aktienanalyse

What does Oncosil Medical do?

Oncosil Medical Ltd is an Australian company specializing in the development and distribution of innovative medical products for the treatment of cancer. The company was founded in 2005 and is based in Sydney. The business model of Oncosil Medical is based on research, development, and marketing of products specifically tailored to the needs of cancer patients. The company focuses on developing medical products that aim to improve the effectiveness of radiation therapy and chemotherapy. The core product of Oncosil Medical is the Oncosil implant. It is a small, implantable catheter containing tiny radioactive silicon particles. The implant is directly inserted into the tumor and releases controlled radiation to specifically destroy the tumor. The Oncosil implant is a promising and innovative new treatment option for many cancer patients. It is particularly suitable for patients with locally advanced pancreatic cancer, which is especially difficult to treat. Studies have shown that the Oncosil implant can significantly improve patients' survival rate. Oncosil Medical also provides other products, such as the Microsil transponder. The Microsil transponder is a small implant used in radiation therapy to make the irradiation of the tumor more effective. The transponder is directly inserted into the tumor, allowing medical professionals to precisely target the radiation to the tumor. In addition to developing and marketing innovative medical products, Oncosil Medical also has a research and development department. The company is constantly searching for new cancer treatment methods and works closely with scientists and researchers to develop new technologies. Oncosil Medical operates in several areas. In addition to developing and marketing medical products, the company also offers a training and education program for doctors and medical personnel. The program ensures that all users of Oncosil Medical's products have the necessary skills and knowledge to use the products safely and effectively. The company also has its own regulatory affairs department, which deals with the application for approvals for new products and procedures. This department works closely with authorities and regulatory agencies to ensure that all products from Oncosil Medical comply with applicable regulations and standards. Overall, Oncosil Medical is an innovative and emerging company specializing in the development and marketing of medical products for cancer treatment. With its highly skilled team of scientists, doctors, and qualified professionals, the company stays up to date with the latest research and technology to ensure that its products are always state-of-the-art and provide customers with the best possible treatment option. Oncosil Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Oncosil Medical's Return on Equity (ROE)

Oncosil Medical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Oncosil Medical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Oncosil Medical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Oncosil Medical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Oncosil Medical stock

What is the ROE (Return on Equity) of Oncosil Medical this year?

The ROE of Oncosil Medical this year is -1.15 undefined.

How has the Return on Equity (ROE) of Oncosil Medical developed compared to the previous year?

The ROE of Oncosil Medical has increased by 19.47% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Oncosil Medical?

A high ROE indicates that Oncosil Medical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Oncosil Medical?

A low ROE can indicate that Oncosil Medical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Oncosil Medical affect the company?

A change in ROE (Return on Equity) of Oncosil Medical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Oncosil Medical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Oncosil Medical?

Some factors that can influence Oncosil Medical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Oncosil Medical pay?

Over the past 12 months, Oncosil Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosil Medical is expected to pay a dividend of 0 AUD.

What is the dividend yield of Oncosil Medical?

The current dividend yield of Oncosil Medical is .

When does Oncosil Medical pay dividends?

Oncosil Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncosil Medical?

Oncosil Medical paid dividends every year for the past 0 years.

What is the dividend of Oncosil Medical?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncosil Medical located?

Oncosil Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncosil Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncosil Medical from 9/13/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Oncosil Medical pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Oncosil Medical in the year 2023?

In the year 2023, Oncosil Medical distributed 0 AUD as dividends.

In which currency does Oncosil Medical pay out the dividend?

The dividends of Oncosil Medical are distributed in AUD.